02UL37Z
Supplement Ventricle, Left to No Qualifier with Autologous Tissue Substitute, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 2 Heart and Great Vessels |
| Operation | U Supplement |
| Body Part | L Ventricle, Left |
| Approach | 3 Percutaneous |
| Device | 7 Autologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures add biological or synthetic material to reinforce or enhance a portion of the heart or a great vessel without removing the existing structure. Common examples include patch repair of a septal defect, reinforcing a weakened area of the aortic wall, or placing material to strengthen a valve annulus during repair.
The goal is to shore up tissue that is present but insufficient on its own, whether because of a congenital hole, an aneurysm that has thinned the vessel wall, or a valve structure that needs extra support to function properly. Unlike a replacement, the body's own tissue stays in place and the added material works alongside it.
Patients typically encounter this term in the context of congenital defect closures, aortic aneurysm repairs, and valve repair techniques that use patches, rings, or other reinforcing materials rather than swapping out the whole valve or vessel.
Anatomy & Axis Detail
Ventricle, Left
The left ventricle is the heart's primary pumping chamber, generating the pressure needed to drive blood through the systemic circulation, and its thick muscular wall can develop aneurysmal thinning or rupture after transmural myocardial infarction or from ventricular wall trauma. Supplementing the left ventricle involves patching a weakened or thinned segment of the wall, often following infarct-related aneurysm resection or as part of surgical ventricular restoration, using pericardial or synthetic material to reestablish a more physiologic chamber geometry and reduce wall stress. Because the left ventricle bears the highest intracavitary pressures in the heart, the reinforcing material must be robust enough to withstand repeated systolic loading without dehiscence, and surgeons often assess resulting chamber volume and ejection fraction intraoperatively to confirm the repair has not compromised pump function.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Device: Autologous Tissue Substitute
Autologous Tissue Substitute identifies a device value where material harvested from the patient's own body, such as an autograft, is used to replace or reconstruct a body part. Its defining feature is tissue origin from the patient, setting it apart from Nonautologous Tissue Substitute, sourced from a donor or animal, and Synthetic Substitute, made of manufactured material.
Coding & Documentation
Coders assign Supplement when the note documents that material, biological or synthetic, was added to reinforce or augment existing anatomy, such as closing a septal defect with a patch or buttressing a vessel wall. The documentation should identify the material used and confirm that native tissue was not removed and replaced, only strengthened.
The most frequent error is confusing patch closure of a defect, which is Supplement, with actual replacement of a structure, which requires taking out the original part. Another common mistake is missing that some valve repairs combine Supplement for annuloplasty ring placement with Repair for other steps done in the same operative session, each of which needs its own code.